Chris was just a teenager when he was diagnosed with a rare genetic condition called cystinuria, which causes cystine kidney stones that often require surgery to remove.
One year ago - Mother’s Day 2020, I was two and a half months away from meeting my third and final baby girl. 2020 was a tough year for everyone with the COVID pandemic and living our new normal, but it was about to hit a peak for me when I got news just a month later I would have never fathomed. Read a message from Valarie, baby Delila's mom
https://travere.com/wp-content/uploads/Valarie-and-Delila.jpg15821512superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-05-09 09:47:272021-10-26 07:39:18Cheers to the Rare Moms on Mother’s Day
SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2021 financial results and provided a corporate update.
On February 26, 2021, Travere Therapeutics was honored to have Linda Goler Blount, president of the Black Women’s Health Imperative (BWHI), present a keynote address at our Rare Disease Day program. The opportunity for Travere team members to hear Linda speak came on the heels of the first meeting of the Rare Disease Diversity Coalition, which is led by BWHI. Read more>
https://travere.com/wp-content/uploads/RDDC-logo-black.png3001000superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-04-12 10:42:592021-04-12 10:59:01Rare Disease Diversity Coalition Publishes Roadmap to Achieving Health Equity in Rare Disease
April 1, 2020 — The April edition of PharmaVOICE magazine features our CEO Eric Dube, Ph.D., along with other members of the PharmaVOICE 100 leadership community on their top priorities for the remainder of 2021 and the leadership skills that helped guide them through the pandemic.
View the digital edition >
https://travere.com/wp-content/uploads/PV100-300x228-1.png228300superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-04-01 11:01:212021-04-02 10:03:27Travere President and Chief Executive Officer Eric Dube Featured in PharmaVOICE Trend Tracking
Thomas enjoys many things typical of twelve-year-old kids: sports, time with his friends, and playing video games. But Thomas’ journey has not always followed the typical path for kids his age.
“How do you know you have IgA nephropathy?” asked Gisela’s nephrologist skeptically. Gisela was 30 years old, talking to a nephrologist for the first time in a decade. Read and watch her story.
SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2020 financial results and provided a corporate update.
https://travere.com/wp-content/uploads/Retrophin_SoloMark_FullColor_RGB-300-1.png200200superadminhttps://travere.com/wp-content/uploads/Travere-TxTM_Inline-fullcolor.pngsuperadmin2021-03-02 15:38:572021-03-02 15:42:05Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Chris
Cystinuria, Rare LifeCheers to the Rare Moms on Mother’s Day
Stories & InsightsTravere Therapeutics Reports First Quarter 2021 Financial Results
NewsSAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2021 financial results and provided a corporate update.
Read the full press release >Tiffany
FSGS, Rare LifeRare Disease Diversity Coalition Publishes Roadmap to Achieving Health Equity in Rare Disease
NewsTravere President and Chief Executive Officer Eric Dube Featured in PharmaVOICE Trend Tracking
NewsThomas
PBD-ZSD, Rare LifeGisela
IgAN, Rare LifeDelila
ALGS, Rare LifeTravere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
NewsSAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2020 financial results and provided a corporate update.
Read the full press release >